FUSN Gross Margin

As of 2025-05-25, the Gross Margin of Fusion Pharmaceuticals Inc (FUSN) is 7775.2%.

Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

FUSN Gross Margin - Historical Value
DateValue
2023-12-31 7775.2%
2022-12-31 -
2021-12-31 -
2020-12-31 -
2019-12-31 -
2018-12-31 -
2017-12-31 -
-
-
-
FUSN Gross Margin - Peers Comparison